Literature DB >> 21907094

Genetics and neuropathology of Huntington's disease.

Anton Reiner1, Ioannis Dragatsis, Paula Dietrich.   

Abstract

Huntington's disease (HD) is an autosomal dominant progressive neurodegenerative disorder that prominently affects the basal ganglia, leading to affective, cognitive, behavioral and motor decline. The basis of HD is a CAG repeat expansion to >35 CAG in a gene that codes for a ubiquitous protein known as huntingtin, resulting in an expanded N-terminal polyglutamine tract. The size of the expansion is correlated with disease severity, with increasing CAG accelerating the age of onset. A variety of possibilities have been proposed as to the mechanism by which the mutation causes preferential injury to the basal ganglia. The present chapter provides a basic overview of the genetics and pathology of HD.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907094      PMCID: PMC4458347          DOI: 10.1016/B978-0-12-381328-2.00014-6

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  297 in total

1.  Quantitative neuropathological changes in presymptomatic Huntington's disease.

Authors:  E Gómez-Tortosa; M E MacDonald; J C Friend; S A Taylor; L J Weiler; L A Cupples; J Srinidhi; J F Gusella; E D Bird; J P Vonsattel; R H Myers
Journal:  Ann Neurol       Date:  2001-01       Impact factor: 10.422

2.  Aggregate distribution in frontal and motor cortex in Huntington's disease brain.

Authors:  Willeke M C van Roon-Mom; Virginia M Hogg; Lynette J Tippett; Richard L M Faull
Journal:  Neuroreport       Date:  2006-04-24       Impact factor: 1.837

3.  Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum.

Authors:  S J Kish; K Shannak; O Hornykiewicz
Journal:  Ann Neurol       Date:  1987-09       Impact factor: 10.422

4.  Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study.

Authors:  Sarah A J Reading; Michael A Yassa; Arnold Bakker; Adam C Dziorny; Lisa M Gourley; Venu Yallapragada; Adam Rosenblatt; Russell L Margolis; Elizabeth H Aylward; Jason Brandt; Susumu Mori; Peter van Zijl; Susan S Bassett; Christopher A Ross
Journal:  Psychiatry Res       Date:  2005-09-30       Impact factor: 3.222

Review 5.  Excitotoxic injury of the neostriatum: a model for Huntington's disease.

Authors:  M DiFiglia
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

6.  Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease.

Authors:  D Dawbarn; M E De Quidt; P C Emson
Journal:  Brain Res       Date:  1985-08-12       Impact factor: 3.252

7.  The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

Authors:  D M Mann; R Oliver; J S Snowden
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Characterization of the Huntington's disease (HD) gene homologue in the zebrafish Danio rerio.

Authors:  C A Karlovich; R M John; L Ramirez; D Y Stainier; R M Myers
Journal:  Gene       Date:  1998-09-14       Impact factor: 3.688

9.  Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain.

Authors:  J D Wood; J C MacMillan; P S Harper; P R Lowenstein; A L Jones
Journal:  Hum Mol Genet       Date:  1996-04       Impact factor: 6.150

10.  Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease.

Authors:  L Djoussé; B Knowlton; M Hayden; E W Almqvist; R Brinkman; C Ross; R Margolis; A Rosenblatt; A Durr; C Dode; P J Morrison; A Novelletto; M Frontali; R J A Trent; E McCusker; E Gómez-Tortosa; D Mayo; R Jones; A Zanko; M Nance; R Abramson; O Suchowersky; J Paulsen; M Harrison; Q Yang; L A Cupples; J F Gusella; M E MacDonald; R H Myers
Journal:  Am J Med Genet A       Date:  2003-06-15       Impact factor: 2.802

View more
  45 in total

Review 1.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

2.  Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.

Authors:  Adriano Chiò; Giuseppe Borghero; Gabriella Restagno; Gabriele Mora; Carsten Drepper; Bryan J Traynor; Michael Sendtner; Maura Brunetti; Irene Ossola; Andrea Calvo; Maura Pugliatti; Maria Alessandra Sotgiu; Maria Rita Murru; Maria Giovanna Marrosu; Francesco Marrosu; Kalliopi Marinou; Jessica Mandrioli; Patrizia Sola; Claudia Caponnetto; Gianluigi Mancardi; Paola Mandich; Vincenzo La Bella; Rossella Spataro; Amelia Conte; Maria Rosaria Monsurrò; Gioacchino Tedeschi; Fabrizio Pisano; Ilaria Bartolomei; Fabrizio Salvi; Giuseppe Lauria Pinter; Isabella Simone; Giancarlo Logroscino; Antonio Gambardella; Aldo Quattrone; Christian Lunetta; Paolo Volanti; Marcella Zollino; Silvana Penco; Stefania Battistini; Alan E Renton; Elisa Majounie; Yevgeniya Abramzon; Francesca Luisa Conforti; Fabio Giannini; Massimo Corbo; Mario Sabatelli
Journal:  Brain       Date:  2012-03       Impact factor: 13.501

Review 3.  Reassessing models of basal ganglia function and dysfunction.

Authors:  Alexandra B Nelson; Anatol C Kreitzer
Journal:  Annu Rev Neurosci       Date:  2014       Impact factor: 12.449

4.  Allelic series of Huntington's disease knock-in mice reveals expression discorrelates.

Authors:  Ashish Kumar; Jennifer Zhang; Sara Tallaksen-Greene; Michael R Crowley; David K Crossman; A Jennifer Morton; Thomas Van Groen; Inga Kadish; Roger L Albin; Mathieu Lesort; Peter J Detloff
Journal:  Hum Mol Genet       Date:  2016-02-14       Impact factor: 6.150

Review 5.  Genetically engineered pig models for human diseases.

Authors:  Randall S Prather; Monique Lorson; Jason W Ross; Jeffrey J Whyte; Eric Walters
Journal:  Annu Rev Anim Biosci       Date:  2013-01-03       Impact factor: 8.923

6.  Fractionation for Resolution of Soluble and Insoluble Huntingtin Species.

Authors:  Joseph Ochaba; Eva L Morozko; Jacqueline G O'Rourke; Leslie M Thompson
Journal:  J Vis Exp       Date:  2018-02-27       Impact factor: 1.355

Review 7.  A family affair: brain abnormalities in siblings of patients with schizophrenia.

Authors:  Marcel E Moran; Hilleke Hulshoff Pol; Nitin Gogtay
Journal:  Brain       Date:  2013-05-22       Impact factor: 13.501

Review 8.  Neurofilament Light Chain as a Biomarker, and Correlation with Magnetic Resonance Imaging in Diagnosis of CNS-Related Disorders.

Authors:  Zahra Alirezaei; Mohammad Hossein Pourhanifeh; Sarina Borran; Majid Nejati; Hamed Mirzaei; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.590

9.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

10.  Shedding a new light on Huntington's disease: how blood can both propagate and ameliorate disease pathology.

Authors:  Marie Rieux; Melanie Alpaugh; Giacomo Sciacca; Martine Saint-Pierre; Maria Masnata; Hélèna L Denis; Sébastien A Lévesque; Frank Herrmann; Chantal Bazenet; Alexandre P Garneau; Paul Isenring; Ray Truant; Abid Oueslati; Peter V Gould; Anne Ast; Erich E Wanker; Steve Lacroix; Francesca Cicchetti
Journal:  Mol Psychiatry       Date:  2020-06-08       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.